Ionian Technologies signs agreement with Roche Diagnostics

Posted on: Thu, 12 Nov 2009 14:18:00 EST


Symbols: RHHZY
Nov 12, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --
RHHZY | Quote | Chart | News | PowerRating -- Ionian Technologies, Inc., a biotechnology company, has signed an agreement with Roche Diagnostics Corp., a division of Roche Holding, Ltd. Both Ionian and Roche Diagnostics are based in the US.

Under the terms of the agreement, Roche Diagnostics will identify new applications and customers for Ionian's isothermal nucleic acid amplification technology and will bring these opportunities to Ionian.. Roche Diagnostics will have exclusive manufacturing rights for these specific opportunities upon commercialization.

NEAR Assay(TM), Ionian's isothermal amplification technology, is used for the detection of both DNA and RNA from bacterial or viral pathogens.

Deal Type    Partnership
Sub-Category Commercialization
Deal Status Announced: 2009-11-12

Deal Participants

Partner 1 (Company) Ionian Technologies, Inc.
Partner 2 (Company) Roche Diagnostics Corp.
Partner 3 (Company) Roche Holding, Ltd.

For full details on (RHHZY) RHHZY. (RHHZY) has Short Term PowerRatings at TradingMarkets. Details on (RHHZY) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.